Early Pipeline Market Access Evaluations

August 4, 2020 Summer Foote

In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for strategic input and leadership to help assess the access implications for both early pipeline assets in the company’s portfolio and external assets under consideration for potential acquisition and licensing, the VP of Cell Therapy Market Access turned to Business Talent Group.

BTG delivered a seasoned commercialization strategy and global market access executive to provide fully remote strategic and project management consulting. Collaborating with Early Asset and Global Market Access teams, she delivered recommendations on business development opportunities, conducted due diligence, and provided the planning necessary to bring informed, data-driven recommendations for pipeline prioritization and portfolio strategy.

Previous Article
Managing Patient / HCP Promotions Process in Biopharma
Managing Patient / HCP Promotions Process in Biopharma

The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would sup...

Next Article
Market Access Sales Training and Support
Market Access Sales Training and Support

The pharmaceutical reimbursement landscape has grown increasingly complex and—thanks to an intensifying foc...

Get our free guide to working with on-demand talent.

Read Now